REQUEST A DEMO
Total
USD $0.00
Search more companies

Teleflex Medical Asia Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Management Consulting Services
Full name: Teleflex Medical Asia Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western); Secondary Business Activity: management consultancy services (provides accounting and support services to the related corporation)

Headquarters
83 Clemenceau Avenue, #05-05-08 Ue Square, Singapore
Singapore; Singapore; Postal Code: 239920

Contact Details: Purchase the Teleflex Medical Asia Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Teleflex Medical Asia Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Teleflex Medical Asia Pte. Ltd. report to view the information.
Incorporation Date:
September 18, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Teleflex Medical Asia Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
8.65%
Total operating revenue
8.65%
Net Profit (Loss) for the Period
-72.17%
Total assets
-8.92%
Total equity
-38.75%
Net Profit Margin
-9.04%
Return on Equity (ROE)
-17.95%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?